International Society for Human and Animal Mycology (ISHAM) One Health Sporotrichosis Working Group Proceedings - Bogota, Colombia, 2024 INFOCUS Conference.
Alyson M Cavanaugh, Amanda Ribeiro Dos Santos, Carolina Melchior Prado, Jose Pereira Brunelli, Pamela Thomson, Isabella Gremião, Dallas J Smith, Rodrigo Almeida-Paes, Regielly Caroline Raimundo Cognialli, Sandro Antonio Pereira, Eelco F J Meijer, Diego H Caceres, Nancy Chow, Shawn R Lockhart, Dayvison Francis Saraiva Freitas, Vanice Rodrigues Poester, Giovanni L Breda, Francelise Bridi Cavassin, Sandro Rogerio Almeida, Maria Adelaide Millington, Daniela Aguirre, Tom Chiller, Flavio Queiroz-Telles
{"title":"International Society for Human and Animal Mycology (ISHAM) One Health Sporotrichosis Working Group Proceedings - Bogota, Colombia, 2024 INFOCUS Conference.","authors":"Alyson M Cavanaugh, Amanda Ribeiro Dos Santos, Carolina Melchior Prado, Jose Pereira Brunelli, Pamela Thomson, Isabella Gremião, Dallas J Smith, Rodrigo Almeida-Paes, Regielly Caroline Raimundo Cognialli, Sandro Antonio Pereira, Eelco F J Meijer, Diego H Caceres, Nancy Chow, Shawn R Lockhart, Dayvison Francis Saraiva Freitas, Vanice Rodrigues Poester, Giovanni L Breda, Francelise Bridi Cavassin, Sandro Rogerio Almeida, Maria Adelaide Millington, Daniela Aguirre, Tom Chiller, Flavio Queiroz-Telles","doi":"10.1093/mmy/myaf101","DOIUrl":null,"url":null,"abstract":"<p><p>Sporothrix brasiliensis, an emerging fungal threat, is spreading through South America with more than five countries in the Americas now reporting cases. Compared to other species, S. brasiliensis is more virulent and its primary transmission route to humans is from direct contact with infected cats. The increasing number of cases across South America and the challenges in preventing zoonotic transmission pose a significant and growing public health concern. On November 23, 2024, the International Society for Human and Animal Mycology One Health Sporotrichosis Working Group held a symposium to discuss current challenges and potential strategies. This article represents an overview of the discussions that occurred during the symposium focusing on four broad categories: identifying and monitoring introduction of S. brasiliensis in new regions; diagnosis; treatment of humans and cats; preventing and controlling the spread of S. brasiliensis. Overarching themes from all four categories included a gap in the scientific understanding needed to effectively guide public health action and clinical care and the need for multidisciplinary collaboration to address the problem. A better understanding of the epidemiology, including transmission, and optimal diagnostics and clinical treatments are needed. Public health activities with a One Health approach, including surveillance, health education, prevention, and control efforts may benefit from innovative strategies that involve microbiologists, veterinarians, physicians, and public health officials.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myaf101","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Sporothrix brasiliensis, an emerging fungal threat, is spreading through South America with more than five countries in the Americas now reporting cases. Compared to other species, S. brasiliensis is more virulent and its primary transmission route to humans is from direct contact with infected cats. The increasing number of cases across South America and the challenges in preventing zoonotic transmission pose a significant and growing public health concern. On November 23, 2024, the International Society for Human and Animal Mycology One Health Sporotrichosis Working Group held a symposium to discuss current challenges and potential strategies. This article represents an overview of the discussions that occurred during the symposium focusing on four broad categories: identifying and monitoring introduction of S. brasiliensis in new regions; diagnosis; treatment of humans and cats; preventing and controlling the spread of S. brasiliensis. Overarching themes from all four categories included a gap in the scientific understanding needed to effectively guide public health action and clinical care and the need for multidisciplinary collaboration to address the problem. A better understanding of the epidemiology, including transmission, and optimal diagnostics and clinical treatments are needed. Public health activities with a One Health approach, including surveillance, health education, prevention, and control efforts may benefit from innovative strategies that involve microbiologists, veterinarians, physicians, and public health officials.
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.